Cargando…
Strategies for monitoring and combating resistance to combination kinase inhibitors for cancer therapy
Targeted therapies such as kinase inhibitors and monoclonal antibodies have dramatically altered cancer care in recent decades. Although these targeted therapies have improved patient outcomes in several cancer types, resistance ultimately develops to these agents. One potential strategy proposed to...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399860/ https://www.ncbi.nlm.nih.gov/pubmed/28431544 http://dx.doi.org/10.1186/s13073-017-0431-3 |